Trials / Conditions / Gastrointestinal Neoplasm

Gastrointestinal Neoplasm

15 registered clinical trials studyying Gastrointestinal Neoplasm — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	AI for Onsite Cytology Evaluation in Endoscopic Ultrasound NCT07228689	Orlando Health, Inc.	—
Recruiting	The ctDNA-RECIST Trial Part One NCT06562348	Karen-Lise Garm Spindler	Phase 2
Not Yet Recruiting	Prospective Cohort Study on the Safety and Efficacy of Endorobotics for Endoscopic Submucosal Dissection (Endo NCT06726798	Chinese University of Hong Kong	N/A
Recruiting	Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection NCT06134687	Baylor College of Medicine	N/A
Recruiting	Traction vs. No Traction in Colonic ESD NCT06159634	Baylor College of Medicine	N/A
Completed	Disposable Powered Articulating Linear Cutter Stapler in Gastrointestinal Tissue Cutting and Anastomosis NCT05320029	Fengh Medical Co., Ltd.	N/A
Completed	A Study of XmAb®18087 in Subjects With NET and GIST NCT03411915	Xencor, Inc.	Phase 1
Completed	Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection NCT02785783	Portsmouth Hospitals NHS Trust	N/A
Completed	Primary Tumour Response to Induction Chemotherapy in Synchronously Metastasized Colorectal Cancer NCT05172635	Klinik Favoriten	—
Completed	Assessing the Patient Experience in Cancer Care NCT01621295	Mayo Clinic	—
Completed	First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer. NCT01129310	AHS Cancer Control Alberta	Phase 2
Withdrawn	Kinase Genotyping of Gastro Intestinal Stomach Tumors (GISTs) From Patients Enrolled in Pfizer A6181112 Phase NCT00640692	Oregon Health and Science University	—
Completed	A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors NCT00465725	Poniard Pharmaceuticals	Phase 1
Approved For Marketing	A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treat NCT00094029	Pfizer	—
Completed	Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis NCT00052962	National Cancer Institute (NCI)	Phase 3